Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-047289
Filing Date
2010-05-10
Accepted
2010-05-10 17:00:52
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c00554e10vq.htm 10-Q 398916
2 EXHIBIT 31.1 c00554exv31w1.htm EX-31.1 8715
3 EXHIBIT 31.2 c00554exv31w2.htm EX-31.2 8709
4 EXHIBIT 32.1 c00554exv32w1.htm EX-32.1 3261
5 EXHIBIT 32.2 c00554exv32w2.htm EX-32.2 3300
  Complete submission text file 0000950123-10-047289.txt   424286
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 10817164
SIC: 2834 Pharmaceutical Preparations